These NPs exert preventive and therapeutic effects on PF and IPF by modulating pathways like the TGF-β1-mediated Smad pathway, Nox4-Nrf2 pathway, NF-κB pathway, and AMPK pathway. Here, TGFB1 is linked to idiopathic pulmonary fibrosis.